PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1984 September; 77(9): 788–792.
PMCID: PMC1440011

Surfactant treatment for respiratory distress syndrome: a review.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (674K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Adams FH, Towers B, Osher AB, Ikegami M, Fujiwara T, Nozaki M. Effects of tracheal instillation of natural surfactant in premature lambs. I. Clinical and autopsy findings. Pediatr Res. 1978 Aug;12(8):841–848. [PubMed]
  • Bangham AD, Morley CJ, Phillips MC. The physical properties of an effective lung surfactant. Biochim Biophys Acta. 1979 Jun 21;573(3):552–556. [PubMed]
  • Baylen BG, Ogata H, Ikegami M, Jacobs HC, Jobe AH, Emmanouilides GC. Left ventricular performance and regional blood flows before and after ductus arteriosus occlusion in premature lambs treated with surfactant. Circulation. 1983 Apr;67(4):837–843. [PubMed]
  • Chu J, Clements JA, Cotton EK, Klaus MH, Sweet AY, Tooley WH, Bradley BL, Brandorff LC. Neonatal pulmonary ischemia. I. Clinical and physiological studies. Pediatrics. 1967 Oct;40(4 Suppl):709–782. [PubMed]
  • Clyman RI, Jobe A, Heymann M, Ikegami M, Roman C, Payne B, Mauray F. Increased shunt through the patent ductus arteriosus after surfactant replacement therapy. J Pediatr. 1982 Jan;100(1):101–107. [PubMed]
  • Cutz E, Enhörning G, Robertson B, Sherwood WG, Hill DE. Hyaline membrane disease. Effect of surfactant prophylaxis on lung morphology in premature primates. Am J Pathol. 1978 Sep;92(3):581–594. [PubMed]
  • Enhorning G. Photography of peripheral pulmonary airway expansion as affected by surfactant. J Appl Physiol Respir Environ Exerc Physiol. 1977 Jun;42(6):976–979. [PubMed]
  • Enhörning G, Grossman G, Robertson B. Tracheal deposition of surfactant before the first breath. Am Rev Respir Dis. 1973 Jun;107(6):921–927. [PubMed]
  • Enhörning G, Grossmann G, Robertson B. Pharyngeal deposition of surfactant in the premature rabbit fetus. Biol Neonate. 1973;22(1):126–132. [PubMed]
  • Enhorning G, Hill D, Sherwood G, Cutz E, Robertson B, Bryan C. Improved ventilation of prematurely delivered primates following tracheal deposition of surfactant. Am J Obstet Gynecol. 1978 Nov 1;132(5):529–536. [PubMed]
  • Enhörning G, Robertson B. Lung expansion in the premature rabbit fetus after tracheal deposition of surfactant. Pediatrics. 1972 Jul;50(1):58–66. [PubMed]
  • Enhorning G, Robertson B, Milne E, Wagner R. Radiologic evaluation of the premature newborn rabbit after pharyngeal deposition of surfactant. Am J Obstet Gynecol. 1975 Feb 15;121(4):475–480. [PubMed]
  • Fujiwara T, Maeta H, Chida S, Morita T, Watabe Y, Abe T. Artificial surfactant therapy in hyaline-membrane disease. Lancet. 1980 Jan 12;1(8159):55–59. [PubMed]
  • Glatz T, Ikegami M, Jobe A. Metabolism of exogenously administered natural surfactant in the newborn lamb. Pediatr Res. 1982 Sep;16(9):711–715. [PubMed]
  • Halliday HL, McClure G, Reid MM, Lappin TR, Meban C, Thomas PS. Controlled trial of artificial surfactant to prevent respiratory distress syndrome. Lancet. 1984 Mar 3;1(8375):476–478. [PubMed]
  • Hallman M, Merritt TA, Schneider H, Epstein BL, Mannino F, Edwards DK, Gluck L. Isolation of human surfactant from amniotic fluid and a pilot study of its efficacy in respiratory distress syndrome. Pediatrics. 1983 Apr;71(4):473–482. [PubMed]
  • Hurt H, Kattwinkel J, Roth S. Artificial surfactant treatment in lambs with severe respiratory distress syndrome: a controlled study. J Pediatr. 1983 Mar;102(3):450–453. [PubMed]
  • Ikegami M, Silverman J, Adams FH. Restoration of lung pressure-volume characteristics with various phospholipids. Pediatr Res. 1979 Jun;13(6):777–780. [PubMed]
  • Jacobs H, Jobe A, Ikegami M, Glatz T, Jones SJ, Barajas L. Premature lambs rescued from respiratory failure with natural surfactant: clinical and biophysical correlates. Pediatr Res. 1982 Jun;16(6):424–429. [PubMed]
  • Jobe A, Ikegami M, Glatz T, Yoshida Y, Diakomanolis E, Padbury J. Duration and characteristics of treatment of premature lambs with natural surfactant. J Clin Invest. 1981 Feb;67(2):370–375. [PMC free article] [PubMed]
  • Morley CJ, Banhham AD, Johnson P, Thorburn GD, Jenkin G. Physical and physiological properties of dry lung surfactant. Nature. 1978 Jan 12;271(5641):162–163. [PubMed]
  • Morley CJ, Bangham AD, Miller N, Davis JA. Dry artificial lung surfactant and its effect on very premature babies. Lancet. 1981 Jan 10;1(8211):64–68. [PubMed]
  • Morley C, Robertson B, Lachmann B, Nilsson R, Bangham A, Grossmann G, Miller N. Artificial surfactant and natural surfactant. Comparative study of the effects on premature rabbit lungs. Arch Dis Child. 1980 Oct;55(10):758–765. [PMC free article] [PubMed]
  • Nilsson R, Grossmann G, Robertson B. Lung surfactant and the pathogenesis of neonatal bronchiolar lesions induced by artificial ventilation. Pediatr Res. 1978 Apr;12(4 Pt 1):249–255. [PubMed]
  • Robertson B. Surfactant substitution; experimental models and clinical applications. Lung. 1980;158(2):57–68. [PubMed]
  • Robertson B, Enhorning G. The alveolar lining of the premature newborn rabbit after pharyngeal deposition of surfactant. Lab Invest. 1974 Jul;31(1):54–59. [PubMed]
  • ROBILLARD E, ALARIE Y, DAGENAIS-PERUSSE P, BARIL E, GUILBEAULT A. MICROAEROSOL ADMINISTRATION OF SYNTHETIC BETA-GAMMA-DIPALMITOYL-L-ALPHA-LECITHIN IN THE RESPIRATORY DISTRESS SYNDOME: A PRELIMINARY REPORT. Can Med Assoc J. 1964 Jan 11;90:55–57. [PMC free article] [PubMed]
  • Schneider HA, Hallman M, Benirschke K, Gluck L. Human surfactant: a therapeutic trial in premature rabbits. J Pediatr. 1982 Apr;100(4):619–622. [PubMed]
  • Shannon DC, Kazemi H, Merrill EW, Smith KA, Wong PS. Restoration of volume-pressure curves with a lecithin fog. J Appl Physiol. 1970 Apr;28(4):470–473. [PubMed]
  • Smyth JA, Metcalfe IL, Duffty P, Possmayer F, Bryan MH, Enhorning G. Hyaline membrane disease treated with bovine surfactant. Pediatrics. 1983 Jun;71(6):913–917. [PubMed]
  • Tanaka Y, Takei T. Lung surfactants. I. Comparison of surfactants prepared from lungs of calf, ox, dog and rabbit. Chem Pharm Bull (Tokyo) 1983 Nov;31(11):4091–4099. [PubMed]
  • Tanaka Y, Takei T, Kanazawa Y. Lung surfactants. II. Effects of fatty acids, triacylglycerols and protein on the activity of lung surfactant. Chem Pharm Bull (Tokyo) 1983 Nov;31(11):4100–4109. [PubMed]
  • Tanaka Y, Takei T, Masuda K. Lung surfactants. III. Correlations among activities in vitro, in situ and in vivo, and chemical composition. Chem Pharm Bull (Tokyo) 1983 Nov;31(11):4110–4115. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press